BOSTON SCIENTIFIC CORPORATION RESONATE HF CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
|
Back to Search Results |
|
Model Number G547 |
Device Problems
Premature Discharge of Battery (1057); Failure to Capture (1081); Use of Device Problem (1670); Low impedance (2285); Battery Problem (2885); High Capture Threshold (3266)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 07/06/2023 |
Event Type
Injury
|
Event Description
|
It was reported that the battery of this recently implanted cardiac resynchronization therapy defibrillator (crt-d) was suspected to be depleting prematurely as a recent longevity estimate indicated approximately two years remaining.It was noted that the right ventricular (rv) lead threshold measurement at implant was 0.4v@0.4ms.At this time, right ventricular autothreshold (rvat) testing was in suspension, right ventricular autocapture (rvac) was unavailable, and rv outputs were 5.0v @ 0.4ms.In addition, rv impedance measurements were low and have been trending downward since implant.A request was made to have data from this device analyzed.Data analysis confirmed the battery appeared to be depleting more quickly than expected.This crt-d system remains in service, however urgent device replacement was recommended.This patient is not pacer dependent, and no adverse patient effects were reported.
|
|
Manufacturer Narrative
|
If pertinent information is provided in the future, a supplemental report will be submitted.
|
|
Event Description
|
It was reported that the battery of this recently implanted cardiac resynchronization therapy defibrillator (crt-d) was suspected to be depleting prematurely as a recent longevity estimate indicated approximately two years remaining.It was noted that the right ventricular (rv) lead threshold measurement at implant was 0.4v@0.4ms.At this time, right ventricular auto threshold (rvat) testing was in suspension, right ventricular autocapture (rvac) was unavailable, and rv outputs were 5.0v @ 0.4ms.In addition, rv impedance measurements were low and have been trending downward since implant.A request was made to have data from this device analyzed.Data analysis confirmed the battery appeared to be depleting more quickly than expected.This crt-d system remains in service, however urgent device replacement was recommended.This patient is not pacer dependent, and no adverse patient effects were reported.Additional information received reported that this cardiac resynchronization therapy defibrillator (crt-d) was explanted, replaced, and returned for analysis.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
If pertinent information is provided in the future, a supplemental report will be submitted.The product has been received for analysis.This report will be updated upon completion of analysis.
|
|
Manufacturer Narrative
|
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the product was performed.Review of device memory confirmed the presence of a higher than normal current drain condition.Electrical testing and analysis were then conducted, which isolated the high current to an anomaly in an oxide layer within a custom integrated circuit component.This anomaly caused a high current drain, which over time resulted in the reported clinical observations.
|
|
Event Description
|
It was reported that the battery of this recently implanted cardiac resynchronization therapy defibrillator (crt-d) was suspected to be depleting prematurely as a recent longevity estimate indicated approximately two years remaining.It was noted that the right ventricular (rv) lead threshold measurement at implant was 0.4v@0.4ms.At this time, right ventricular autothreshold (rvat) testing was in suspension, right ventricular autocapture (rvac) was unavailable, and rv outputs were 5.0v @ 0.4ms.In addition, rv impedance measurements were low and have been trending downward since implant.A request was made to have data from this device analyzed.Data analysis confirmed the battery appeared to be depleting more quickly than expected.This crt-d system remains in service, however urgent device replacement was recommended.This patient is not pacer dependent, and no adverse patient effects were reported.Additional information received reported that this cardiac resynchronization therapy defibrillator (crt-d) was explanted, replaced, and returned for analysis.No additional adverse patient effects were reported.
|
|
Search Alerts/Recalls
|
|
|